TANDEM DIABETES CARE INC - COM NEW (TNDM)

Historical Portfolio Holders from Q3 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q1 2024
72.3 M
Holdings value Q1 2024
$2.56 B
Value change Q1 2024
+$131 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
277
Number of buys Q1 2024
165
Number of sells Q1 2024
-104
Average buys Q1 2024 %
+0.004%
Average sells Q1 2024 %
-0.001%
CUSIP
875372203
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 72.3 M $2.56 B +$131 M $35.41 277
2023 Q4 69.8 M $2.07 B +$45.5 M $29.58 261
2023 Q3 68.6 M $1.42 B +$36.7 M $20.77 221
2023 Q2 65.9 M $1.62 B -$79.8 M $24.54 236
2023 Q1 68 M $2.76 B +$144 M $40.61 269
2022 Q4 64 M $2.87 B +$82 M $44.95 285
2022 Q3 61.8 M $2.96 B +$41.6 M $47.85 276
2022 Q2 61.4 M $3.63 B -$77 M $59.19 318
2022 Q1 59.4 M $6.91 B -$142 M $116.29 361
2021 Q4 60.2 M $9.06 B +$31.9 M $150.52 377
2021 Q3 61.2 M $7.3 B +$275 M $119.38 331
2021 Q2 59 M $5.75 B +$205 M $97.40 295
2021 Q1 57.5 M $5.07 B -$45.6 M $88.25 286
2020 Q4 58.4 M $5.59 B +$258 M $95.68 295
2020 Q3 54.6 M $6.2 B -$68.4 M $113.50 313
2020 Q2 55.3 M $5.46 B +$14.4 M $98.92 297
2020 Q1 55.7 M $3.58 B +$179 M $64.35 264
2019 Q4 54.3 M $3.23 B +$217 M $59.61 271
2019 Q3 49.4 M $2.91 B +$146 M $58.98 259
2019 Q2 46.9 M $3.03 B +$63.9 M $64.52 258
2019 Q1 46.8 M $2.97 B -$41.9 M $63.50 258
2018 Q4 47.2 M $1.79 B +$233 M $37.97 195
2018 Q3 40.6 M $1.74 B +$355 M $42.84 177
2018 Q2 33.4 M $734 M +$323 M $22.02 113
2018 Q1 19 M $94.3 M +$86.6 M $4.96 69
2017 Q4 1.55 M $3.66 M -$15.6 M $2.36 27
2017 Q3 8.18 M $5.97 M +$5.97 M $0.73 4